157 related articles for article (PubMed ID: 27323818)
1. The calpain system is associated with survival of breast cancer patients with large but operable inflammatory and non-inflammatory tumours treated with neoadjuvant chemotherapy.
Storr SJ; Zhang S; Perren T; Lansdown M; Fatayer H; Sharma N; Gahlaut R; Shaaban A; Martin SG
Oncotarget; 2016 Jul; 7(30):47927-47937. PubMed ID: 27323818
[TBL] [Abstract][Full Text] [Related]
2. Low calpain-9 is associated with adverse disease-specific survival following endocrine therapy in breast cancer.
Davis J; Martin SG; Patel PM; Green AR; Rakha EA; Ellis IO; Storr SJ
BMC Cancer; 2014 Dec; 14():995. PubMed ID: 25539577
[TBL] [Abstract][Full Text] [Related]
3. Calpain-1 expression is associated with relapse-free survival in breast cancer patients treated with trastuzumab following adjuvant chemotherapy.
Storr SJ; Woolston CM; Barros FF; Green AR; Shehata M; Chan SY; Ellis IO; Martin SG
Int J Cancer; 2011 Oct; 129(7):1773-80. PubMed ID: 21140455
[TBL] [Abstract][Full Text] [Related]
4. Calpain system protein expression and activity in ovarian cancer.
Zhang S; Deen S; Storr SJ; Chondrou PS; Nicholls H; Yao A; Rungsakaolert P; Martin SG
J Cancer Res Clin Oncol; 2019 Feb; 145(2):345-361. PubMed ID: 30448882
[TBL] [Abstract][Full Text] [Related]
5. Calpain system protein expression in basal-like and triple-negative invasive breast cancer.
Storr SJ; Lee KW; Woolston CM; Safuan S; Green AR; Macmillan RD; Benhasouna A; Parr T; Ellis IO; Martin SG
Ann Oncol; 2012 Sep; 23(9):2289-2296. PubMed ID: 22745213
[TBL] [Abstract][Full Text] [Related]
6. Caspase-3 and caspase-8 expression in breast cancer: caspase-3 is associated with survival.
Pu X; Storr SJ; Zhang Y; Rakha EA; Green AR; Ellis IO; Martin SG
Apoptosis; 2017 Mar; 22(3):357-368. PubMed ID: 27798717
[TBL] [Abstract][Full Text] [Related]
7. Immunhistochemical analysis for expression of calpain 1, calpain 2 and calpastatin in endometrial cancer.
Salehin D; Fromberg I; Haugk C; Dohmen B; Georg T; Bohle RM; Bauerschlag D; Maass N; Friedrich M
Anticancer Res; 2010 Jul; 30(7):2837-43. PubMed ID: 20683020
[TBL] [Abstract][Full Text] [Related]
8. Calpain in Breast Cancer: Role in Disease Progression and Treatment Response.
Storr SJ; Thompson N; Pu X; Zhang Y; Martin SG
Pathobiology; 2015 Sep; 82(3-4):133-41. PubMed ID: 26330354
[TBL] [Abstract][Full Text] [Related]
9. Expression and immunolocalization of the calpain-calpastatin system in the human oocyte.
Ben-Aharon I; Ben-Yosef D; Amit A; Shalgi R
Fertil Steril; 2005 Jun; 83(6):1807-13. PubMed ID: 15950654
[TBL] [Abstract][Full Text] [Related]
10. Calpain-1 is associated with adverse relapse free survival in breast cancer: a confirmatory study.
Pu X; Storr SJ; Ahmad NS; Chan SY; Moseley PM; Televantou D; Cresti N; Boddy A; Ellis IO; Martin SG
Histopathology; 2016 Jun; 68(7):1021-9. PubMed ID: 26496999
[TBL] [Abstract][Full Text] [Related]
11. Over-expression of calpastatin aggravates cardiotoxicity induced by doxorubicin.
Wang Y; Zheng D; Wei M; Ma J; Yu Y; Chen R; Lacefield JC; Xu H; Peng T
Cardiovasc Res; 2013 Jun; 98(3):381-90. PubMed ID: 23455548
[TBL] [Abstract][Full Text] [Related]
12. Expression of the calpain system is associated with poor clinical outcome in gastro-oesophageal adenocarcinomas.
Storr SJ; Pu X; Davis J; Lobo D; Reece-Smith AM; Parsons SL; Madhusudan S; Martin SG
J Gastroenterol; 2013 Nov; 48(11):1213-21. PubMed ID: 23329366
[TBL] [Abstract][Full Text] [Related]
13. Calpain-2 expression is associated with response to platinum based chemotherapy, progression-free and overall survival in ovarian cancer.
Storr SJ; Safuan S; Woolston CM; Abdel-Fatah T; Deen S; Chan SY; Martin SG
J Cell Mol Med; 2012 Oct; 16(10):2422-8. PubMed ID: 22435971
[TBL] [Abstract][Full Text] [Related]
14. 5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial.
Gianni L; Pienkowski T; Im YH; Tseng LM; Liu MC; Lluch A; Starosławska E; de la Haba-Rodriguez J; Im SA; Pedrini JL; Poirier B; Morandi P; Semiglazov V; Srimuninnimit V; Bianchi GV; Magazzù D; McNally V; Douthwaite H; Ross G; Valagussa P
Lancet Oncol; 2016 Jun; 17(6):791-800. PubMed ID: 27179402
[TBL] [Abstract][Full Text] [Related]
15. Calpain-calpastatin system and cancer progression.
Nian H; Ma B
Biol Rev Camb Philos Soc; 2021 Jun; 96(3):961-975. PubMed ID: 33470511
[TBL] [Abstract][Full Text] [Related]
16. The calpain-calpastatin system and cellular proliferation and differentiation in rodent osteoblastic cells.
Murray SS; Grisanti MS; Bentley GV; Kahn AJ; Urist MR; Murray EJ
Exp Cell Res; 1997 Jun; 233(2):297-309. PubMed ID: 9194492
[TBL] [Abstract][Full Text] [Related]
17. Calpain system protein expression in carcinomas of the pancreas, bile duct and ampulla.
Storr SJ; Zaitoun AM; Arora A; Durrant LG; Lobo DN; Madhusudan S; Martin SG
BMC Cancer; 2012 Nov; 12():511. PubMed ID: 23140395
[TBL] [Abstract][Full Text] [Related]
18. Immunhistochemical analysis for expression of calpain 1, calpain 2 and calpastatin in ovarian cancer.
Salehin D; Fromberg I; Haugk C; Dohmen B; Georg T; Bohle RM; Bauerschlag D; Thill M; Friedrich M
Eur J Gynaecol Oncol; 2011; 32(6):628-35. PubMed ID: 22335024
[TBL] [Abstract][Full Text] [Related]
19. [Calpain and calpastatin].
Murachi T
Rinsho Byori; 1990 Apr; 38(4):337-46. PubMed ID: 2195187
[TBL] [Abstract][Full Text] [Related]
20. The role of extracellular and intracellular proteolytic systems in aneurysms of the ascending aorta.
Werner I; Schack S; Richter M; Stock UA; Ahmad Ael-S; Moritz A; Beiras-Fernandez A
Histol Histopathol; 2016 May; 31(5):523-34. PubMed ID: 26582478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
